On November 2, 2021 ALX Oncology Holdings Inc., ("ALX Oncology") (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, reported that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in four upcoming virtual investor conferences (Press release, ALX Oncology, NOV 2, 2021, View Source [SID1234594088]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 30th Annual Healthcare Conference
Format: Fireside chat with analyst, Tiago Fauth
Date: Monday, November 8
Time: 2:40 PM Eastern Time
Webcast link: Available here

Stifel 2021 Healthcare Conference
Format: Fireside chat with analyst, Bradley Canino
Date: Tuesday, November 16
Time: 10:00 AM Eastern Time
Webcast link: Available here

Jefferies 2021 London Healthcare Conference
Format: Fireside chat with analyst, Michael Yee
Date: Thursday, November 18 – Friday, November 19
Webcast link: Available here

Piper Sandler 33rd Virtual Healthcare Conference
Format: Fireside chat with analyst, Christopher Raymond
Date: Monday, November 22
Time: 10:00 AM Eastern Time
Webcast link: Will be made available shortly

A webcast of the fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcasts will be archived for up to 90 days following the fireside chat dates.